Full Version of The International Journal of Targeted Therapies in Cancer from April 2013
April 2013
Advertisement
Advertisement
Trending on Targeted Onc
1
FDA Approves Durvalumab-EV Combo, Expanding MIBC Treatment Options
2
Survey Highlights NMIBC Care Challenges Among US Military Service, Veterans
3
New ACS Guidelines Push for Earlier Prostate Cancer Screening
4
Temab-A Shows Promising Survival in Pretreated Nonsquamous NSCLC
5